Your browser doesn't support javascript.
loading
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk.
Zhang, Hao; Gu, Jie-Mei; Chao, Ai-Jun; Cheng, Qun; Teng, Dong-Hui; Yu, Jin-Ming; Wang, Bing-Wu; Huo, Ya-Nan; Mao, Li; Zhang, Qiu; Yang, Hong; Yan, Shi-Gui; Zhang, Ke-Qin; Zhao, Xue-Ling; Lin, Hua; Pei, Yu; Yuan, Zhong; Dai, Ru-Chun; He, Liang; Chen, Li; Su, Yong-Feng; Deng, Zhong-Liang; You, Li; Ban, Bo; Zhu, Mei; Cao, You-Liang; Zhu, Yi-Kun; Li, Zhi-Jun; Zhang, Zhi; Yi, Cheng-Qing; Lu, Yi-Bing; Wang, Guang; Han, Cui-Cui; Wang, Zhen-Jiang; Li, Xian-Xing; Zhang, Zhen-Lin.
Afiliación
  • Zhang H; Department of Osteoporosis and Bone Diseases, Shanghai Clinical Research Center of Bone Diseases, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.
  • Gu JM; Department of Osteoporosis and Bone Diseases, Shanghai Clinical Research Center of Bone Diseases, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.
  • Chao AJ; Department of Osteo-Internal, Tianjin Hospital, Tianjin, 300211, China.
  • Cheng Q; Department of Osteoporosis, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, China.
  • Teng DH; Department of Orthopedics, Tianjin First Central Hospital, Tianjin, 300192, China.
  • Yu JM; Department of Endocrinology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530016, China.
  • Wang BW; Department of Spine Surgery, Weifang People's Hospital, Weifang, 261000, China.
  • Huo YN; Department of Endocrinology, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, 330006, China.
  • Mao L; Department of Endocrinology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, 223300, China.
  • Zhang Q; Department of Endocrinology, The First Affillated Hospital of Anhui Medical University, Hefei, 230022, China.
  • Yang H; Department of Endocrinology, Ruian People's Hospital, Wenzhou, 325200, China.
  • Yan SG; Department of Orthopedics, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
  • Zhang KQ; Department of Endocrinology, Tongji Hospital of Tongji University, Shanghai, 200065, China.
  • Zhao XL; Department of Orthopedics, First Affillated Hospital of Kunming Medical University, Kunming, 650032, China.
  • Lin H; Metabolic Bone Disease Prevention and Treatment Research Center, Nanjing Drum Tower Hospital, Nanjing, 210008, China.
  • Pei Y; Department of Endocrinology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Yuan Z; Department of Osteoporosis, Nanchang Hongdu Hospital of TCM, Nanchang, 330006, China.
  • Dai RC; Department of Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011, China.
  • He L; Department of Orthopedics, Beijing Jishuitan Hospital, Beijing, 100035, China.
  • Chen L; Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, 250012, China.
  • Su YF; Department of Endocrinology, Inner Mongolia Baogang Hospital, Baotou, 014010, China.
  • Deng ZL; Department of Spine Surgery, The second affiliated hospital of Chongqing medical university, Chongqing, 400010, China.
  • You L; Department of Endocrinology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, 200080, China.
  • Ban B; Department of Endocrinology, Affiliated Hospital of Jining Medical University, Jining, 272007, China.
  • Zhu M; Department of Endocrinology, Tianjin Medical University General Hospital, Tianjin, 300052, China.
  • Cao YL; Department of Orthopedics, The Third People's Hospital of Yunnan Province, Kunming, 650011, China.
  • Zhu YK; Department of Endocrinology, Second Hospital of Shanxi Medical University, Taiyuan, 030001, China.
  • Li ZJ; Department of Rheumatology and Immunology, The First Affillated Hospital of Bengbu Medical College, Bengbu, 233004, China.
  • Zhang Z; Department of Spine Surgery, Suining Central Hospital, Suining, 629000, China.
  • Yi CQ; Department of Orthopedics, Shanghai Pudong Hospital, Shanghai, 201399, China.
  • Lu YB; Department of Endocrinology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, China.
  • Wang G; Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
  • Han CC; Department of Medical, Qilu Pharmaceutical Co., Ltd, Jinan, 250100, China.
  • Wang ZJ; Department of Project, Qilu Pharmaceutical Co., Ltd, Jinan, 250100, China.
  • Li XX; Department of Statistical analysis, Qilu Pharmaceutical Co., Ltd, Jinan, 250100, China.
  • Zhang ZL; Department of Osteoporosis and Bone Diseases, Shanghai Clinical Research Center of Bone Diseases, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China. zhangzl@sjtu.edu.cn.
Acta Pharmacol Sin ; 44(2): 446-453, 2023 Feb.
Article en En | MEDLINE | ID: mdl-35896694
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Osteoporosis / Osteoporosis Posmenopáusica / Conservadores de la Densidad Ósea / Biosimilares Farmacéuticos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Osteoporosis / Osteoporosis Posmenopáusica / Conservadores de la Densidad Ósea / Biosimilares Farmacéuticos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China